Psychosomatic Disorders, Epigenome, and Gut Microbiota

Area of Science:

• Psychoneuroimmunology
• Gut-Brain Axis Research
• Epigenetics in Health and Disease

Background:

• Psychosomatic disorders link physical symptoms to psychological distress.
• Complex interactions involve endocrine, nervous, and immune systems.
• Gut microbiota (GM) dysbiosis and epigenetic alterations are implicated in pathogenesis.

Purpose of the Study:

• To review the role of epigenetic dysregulation and GM in psychosomatic disorders.
• To examine therapeutic interventions modulating the gut-brain axis epigenetically.
• To highlight challenges and future directions in this research area.

Main Methods:

• Literature review focusing on epigenetic mechanisms and GM.
• Analysis of gene expression changes (e.g., GRM2, BDNF, NR3C1).
• Examination of GM composition and metabolite influences on neurobiology and immunity.

Main Results:

• Epigenetic dysregulation impacts genes crucial for psychosomatic disorders.
• GM dysbiosis and its metabolites affect immune function and neurobiological pathways.
• Therapeutic strategies like probiotics and dietary changes show promise.

Conclusions:

• Epigenetics and GM are key players in psychosomatic disorder development.
• Targeting the gut-brain axis epigenetically offers therapeutic potential.
• Further research using models like organoids is needed to understand inter-organ interactions.